The intracellular flux rate through adenosine kinase (adenosine-AMP) in the well-oxygenated heart was investigated, and the relation of the AMP-adenosine metabolic cycle (AMPw±adenosine) to transmethylation (S-adenosylhomocysteine [SAHI -*adenosine) and coronary flow was determined. Adenosine kinase was blocked in isolated guinea pig hearts by infusion of iodotubercidin in the presence of the adenosine deaminase blocker erythro-9-(2-hydroxy-3-nonyl)adenine (5 ,umol/L).lodotubercidin (1 nmol/L to 4 ,umol/L) caused graded increases in venous effluent concentrations of adenosine, from 8±3 to 145±32 nmol/L (mean±SEM, n=3), and in coronary flow, which increased to maximal levels. Flow increases were completely abolished by adenosine deaminase (5 to 10 U/mL). Interstitial adenosine concentrations, estimated using a mathematical model, increased from 22 nmol/L during control conditions to 420 nmol/L during maximal vasodilation. The possibility that iodotubercidin caused increased venous adenosine by interfering with myocardial energy metabolism was ruled out in separate 31P nuclear magnetic resonance experiments. To estimate total normoxic myocardial production of adenosine (AMP-adenosine*-SAH), the time course of coronary venous adenosine release was measured during maximal inhibition of adenosine kinase with 30 ,umol/L iodotubercidin. Adenosine release increased more than 15-fold over baseline, reaching a new steady-state value of 3.4±0.3 nmol* min-' g`-(n=5) after 4 minutes. In parallel experiments, the relative roles of AMP hydrolysis and transmethylation (SAH hydrolysis) were determined, using adenosine dialdehyde (10 ,umol/L) to block SAH hydrolase. In these experiments, adenosine release increased to similar levels of 3.4±0.5 nmol min' * g1 (n=6) during inhibition of adenosine deaminase and adenosine kinase. It is concluded that (1) maximal increases in coronary flow are elicited by increases in interstitial adenosine concentration to approximately 400 nmol/L, (2) more than 90% of the adenosine produced in the heart is normally rephosphorylated to AMP without escaping into the venous effluent, (3) AMP hydrolysis is the dominant pathway for cardiac adenosine production under normoxic conditions, and (4) the high rate of adenosine salvage is due to rapid turnover of a metabolic cycle between AMP and adenosine. Rapid cycling may serve to amplify the relative importance of AMP hydrolysis over transmethylation in controlling cytosolic adenosine concentrations. (Circ Res. 1993;73:846-856.) KEY WoRDs * coronary flow * S-adenosylhomocysteine * iodotubercidin * adenosine kinase T o further understand the role of adenosine as a local humoral agent in the heart, it is necessary to improve the knowledge of the pathways for adenosine metabolism and transport and to define more precisely the coronary sensitivity for endogenous adenosine. In particular, there are questions concerning the mechanisms of myocardial adenosine production during normoxia and the relative rates of venous adenosine efflux and intracellular adenosine...
The effect of allogeneic blood transfusions on tumour growth was studied in the rat. BD IX animals pretreated by five blood transfusions from SD rats were transplanted with two different syngeneic malignant neurogenic tumours (neurinoma, ependymoma). The tumour growth rates in the transfused animals were compared to those of non-transfused controls. No accelerated growth rates of both types of tumours were observed in transfused animals. As these data are in contrast to the findings of other authors, further studies are needed to evaluate the effect of blood transfusions on tumour growth.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.